The government on Wednesday extended the due date for implementation of revised Schedule M -- good manufacturing practices ...

Will significantly enhance service to researchers and institutions across China.

The implementation of the revised Schedule M marks a critical step towards enhancing the quality and safety of pharmaceutical ...

The Union Health Ministry has conditionally extended the deadline for implementing the revised Schedule M, a set of good manufacturing practices for small and medium pharmaceutical companies, till ...

The implementation of revised Schedule M for good manufacturing practices has been conditionally extended to December 31, ...

India's Ministry of Health & Family Welfare extends the Schedule M implementation deadline for small & medium pharma firms with turnover under Rs 250 crore till December 31, 2025.

The Ministry of Health & Family Welfare has conditionally extended the due date for implementation of revised Schedule M (Good Manufacturing Practices provision) in respect of small and medium ...

A ducted plenum is a highly effective solution for maintaining cleanroom integrity, but it requires careful design, ...

Amidst the vibrant economic landscape of Vietnam, the filling equipment market stands as a pivotal player in facilitating the efficiency and growth of various industries. With its robust manufacturing ...

Q1 2025 Earnings Call Transcript February 10, 2025 Arrowhead Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.39 EPS, expectations were $-0.42. Chris Anzalone: Thanks, Vince.

Global partner to pharmaceutical and medtech manufacturers, Uniphar, is expanding its international presence with the launch ...